Executive Summary
Across 50 SEC filings from April 27, 2026, primarily involving non-DJ30 names but with Verizon (DJ30) as a standout, overarching themes include peak proxy season with 20+ AGMs scheduled May-June 2026, positive biotech clinical readouts, M&A activity, and 13F snapshots revealing institutional mega-cap tech bias (e.g., AAPL top holding in 12/15 13Fs). Period-over-period trends show telecom resilience (Verizon Q1 revenue +2.9% YoY, EBITDA +6.7% YoY, EPS +7.6% YoY) contrasting credit/fintech pressures (Golub NAV -4.0% QoQ, Qfin net income -4.4% YoY, Hemab losses +31% YoY to $63.9M); operational metrics highlight Verizon's record postpaid adds (+55k Q1) and Easterly's Core FFO $0.77/share. Critical developments: Verizon raised FY2026 Adjusted EPS guidance to $4.95-$4.99 (+5-6% YoY), RE/MAX M&A forming 180k-agent platform, Veradermics Phase 2/3 hair loss trial success (30-33 hairs/cm² vs placebo 7.3, p<0.0001). Portfolio-level patterns indicate bullish biotech/health catalysts (5/7 positive sentiment), mixed credit (NAV compression amid stable leverage), and heavy tech allocations in 13Fs (~20-30% AAPL/AMZN/GOOG across filers) signaling conviction in DJ30 tech giants like AAPL. Capital allocation favors dividends/FCF (Verizon FCF +4% YoY to $3.8B, Solstice $0.075/share div, Easterly $0.45/share), with low buybacks but SPAC IPOs and shelf registrations for fundraising.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from April 20, 2026.
Investment Signals(12)
- Verizon (8-K)(BULLISH)▲
Q1 revenue +2.9% YoY to $34.4B, adjusted EBITDA +6.7% YoY to $13.4B, EPS +7.6% YoY to $1.28, record postpaid phone adds +55k, raised FY2026 EPS guidance $4.95-$4.99 (+5-6% YoY), FCF +4% YoY to $3.8B
- Easterly Government Properties (8-K)(BULLISH)▲
Q1 Core FFO $0.77/share, raised FY2026 guidance to $3.06-$3.12/share, acquired 297k sq ft campus, $0.45/share dividend (payable May 21), stable $1.7B debt
- Veradermics (S-1)(BULLISH)▲
Phase 2/3 trial success with 30.3-33.0 hairs/cm² non-vellus TAHC vs placebo 7.3 (p<0.0001), fully enrolled Phase 3 male (topline H2 2026), female trial initiated, $9B PHL market
- RE/MAX Holdings (DEFA14A)↓(BULLISH)▲
Definitive agreement to merge with Real Brokerage forming 180k-agent platform across 120+ countries, brands intact post-close H2 2026, tech-enabled growth
- Adagio Medical (8-K)(BULLISH)▲
Positive pivotal results for vCLAS ablation system (announced Apr 26), emerging growth co on Nasdaq
- Greenlane Holdings (8-K)(BULLISH)▲
Regained Nasdaq compliance (min bid $1.00), canceled delisting hearing, board-affiliate lock-up on 162k warrants to Apr 2027
- Vertiv Holdings (8-K)(BULLISH)▲
Closed acquisition of Strategic Thermal Labs Apr 27, expands thermal tech capabilities
- Shoulder Innovations (8-K)(BULLISH)▲
Full commercial launch of InSet I-135RFX humeral stem Apr 27, emerging growth on NYSE
- Solstice Advanced Materials (8-K)(BULLISH)▲
Declared $0.075/share quarterly dividend (payable Jun 10, record May 27), signaling cash flow confidence
- Qfin Holdings (20-F)(BULLISH)▲
FY2025 net revenue +11.9% YoY to RMB19.2B ($2.75B), credit services +19.3% YoY, total assets +18.4% YoY to RMB57B, EPS +6.7% YoY to 22.01
- Golub Capital (8-K)(BULLISH)▲
Portfolio $9.93B across 458 cos (97.7% top IPR), stable 1.25x D/E, boosted credit facility +$525M to $3.13B at lower costs, Apr distributions $0.1875/share
- Information Services Group (8-K)(BULLISH)▲
2026 AGM all proposals passed with 80%+ support (86% quorum), strong director/audit/comp approval
Risk Flags(10)
- Driven Brands (8-K)[HIGH RISK]▼
Fourth credit amendment waives defaults for FY2023-2025 restatements (incl Q1 2026 delay to post-Jun 10), signals ongoing reporting challenges/financial strain
- Hemab Therapeutics (S-1/A)[HIGH RISK]▼
Net losses +31% YoY to $63.9M in 2025 (R&D +44% to $59.6M), cash burn $61.5M, stockholders’ deficit to $(176.6M) despite $156M Series C raise
- Golub Capital (8-K)[MEDIUM RISK]▼
NAV/share -4.0% QoQ to $24.14 (unrealized losses from credit spreads), despite solid 97.7% top IPR
- Qfin Holdings (20-F)[MEDIUM RISK]▼
FY2025 net income -4.4% YoY to RMB6.0B, platform services -4.1% YoY, loan fees -45.1% YoY, provisions for credit losses up significantly
- Verizon (8-K)[MEDIUM RISK]▼
Unsecured debt +8.7% QoQ to $142.5B (net $130.1B), wireless service revenue guided flat FY2026 (80bps Q1 outage hit), Frontier debt repayment ongoing
- Oppenheimer Holdings (8-K)[MEDIUM RISK]▼
$70M 'Cash Sweep' settlement (vs $440M sought), impacts Q1 2026 earnings (release May 1), tax-deductible but material hit
- Velo3D (8-K/A)[MEDIUM RISK]▼
CEO performance options tied to aggressive market cap milestones ($1B-$10B in 5yrs), risks non-vesting if missed, replaces annual grants thru 2029
- Keenova Therapeutics (DEF 14A)[MEDIUM RISK]▼
Post-merger/spin-off risks incl unrealized synergies, higher debt, regulatory/litigation from Endo deal
- RRE Ventures (S-1/A)[MEDIUM RISK]▼
SPAC IPO with founder shares forfeitable, warrants at $11.50 (adjustable if < $9.20), redeemable at $0.01 if shares >=$18
- Avient Corp (8-K)↓[LOW RISK]▼
CFO Jamie Beggs resigns Jun 1 (no disagreements), internal replacement Joe Di Salvo
Opportunities(10)
- Verizon/Catalyst: Raised Guidance↓(OPPORTUNITY)◆
FY2026 mobility revenue +2-3% (~$93B), FCF $21.5B+ (+7% YoY), capex $16-16.5B; trade debt paydown post-Frontier acquisition
- Veradermics/Clinical Readouts↓(OPPORTUNITY)◆
Male Phase 3 topline H2 2026, female Phase 2/3 ongoing (552 pts), first oral non-hormonal PHL therapy in $9B market, patents to 2043
- RE/MAX/M&A Close↓(OPPORTUNITY)◆
H2 2026 close creates tech-enabled 180k-agent global platform, brands independent, undervalued vs peers on agent network scale
- Easterly/Acquisitions↓(OPPORTUNITY)◆
FY2026 $50M acquisitions + $50-100M development, stable 10.7M sq ft portfolio leased to govt, Core FFO guide up
- 13F Filers/Tech Overweight(OPPORTUNITY)◆
12/15 13Fs top-heavy AAPL (e.g., ProFunds $2.34B, 9M shares), AMZN/GOOG; signals conviction in DJ30 tech amid AI tailwinds
- Greenlane/Nasdaq Stability↓(OPPORTUNITY)◆
Post-compliance, monitor turnaround; lock-ups support stability thru 2027
- Adagio Medical/Pivotal Data↓(OPPORTUNITY)◆
vCLAS system results position for potential FDA path, emerging growth on Nasdaq
- Solstice/Dividends↓(OPPORTUNITY)◆
$0.075/share Q dividend (Jun 10 pay), consistent payout signals FCF strength
- Vertiv/M&A Synergies↓(OPPORTUNITY)◆
Strategic Thermal Labs integration enhances data center cooling amid AI demand
- Golub Capital/Liquidity Boost↓(OPPORTUNITY)◆
$1.85B liquidity, 1.25x leverage stable, distributions intact despite NAV dip
Sector Themes(6)
- Proxy Season Peak◆
25/50 filings are proxies/DEFA14A (e.g., MetaVia Jun8, Velo3D Jun10, Fortrea Jun9), all boards recommend FOR; watch say-on-pay frequency (1yr favored), equity plan increases (e.g., Velo3D +2.86M shares), potential for activist pushback [IMPLICATION: Heightened governance scrutiny, low opposition so far]
- Biotech/Health Catalysts◆
5/7 positive (Veradermics 30%+ hair growth p<0.0001, Adagio pivotal, Shoulder launch); contrasts Hemab losses +31% YoY; upcoming H2 2026 readouts [IMPLICATION: Alpha in clinical winners, $9B PHL market outlier]
- Institutional Tech Bias◆
15 13F-HRs (total AUM $100B+) with AAPL top in 12 (avg 10-20% portfolio, e.g., ProFunds 9.2M shares $2.34B), AMZN/GOOG next; sole voting power [IMPLICATION: Bullish DJ30 tech conviction, follow for Q2 changes]
- Credit/Fintech Mixed◆
NAV/income pressures (Golub -4% QoQ, Qfin income -4.4% YoY, Driven restatements) but revenue/liquidity resilient (Qfin +11.9% rev, Golub +$525M facility); stable leverage 1.2-1.25x [IMPLICATION: Selective opportunities in high IPR portfolios]
- Capital Returns Steady◆
Dividends dominant (Easterly/Solstice/Golub distributions, Verizon FCF +4% YoY); low buybacks, but ATM issuance (Easterly 94k shares $2.1M) [IMPLICATION: Defensive yield amid volatility]
- M&A Momentum◆
RE/MAX global platform, Vertiv thermal, Easterly campus; shelf/IPOs (Pintec F-3, RRE SPAC 25M units) signal capital for deals [IMPLICATION: Consolidation in real estate/tech/health]
Watch List(8)
Monitor FY wireless flat guide vs Q1 strength, Frontier debt payoff by YE2026, ops cash $37.5-38B [Ongoing]
Male registration trial data H2 2026, female 2/3 initiated (552 pts) [H2 2026]
Q1 2026 10-Q/earnings May 1 post-$70M settlement impact [May 1, 2026]
H2 2026 approvals for Real Brokerage merger [H2 2026]
- Proxy AGMs Cluster👁
Velo3D/Fortrea/uniQure/MIAX Jun9-16 (CEO comp, equity plans, auditors); low risk but watch votes [May-Jun 2026]
Q1 2026 financials due 45 days post-Jun10, ongoing delays [Post-Jun 2026]
- 13F Filers/Q2 Changes👁
ProFunds/B. Riley/Private Advisor (AAPL/AMZN heavy) for rotation from Mar31 2026 snapshot [Jul 2026]
New CFO Joe Di Salvo effective Jun1, monitor Q2 execution [Jun 1, 2026]
Filing Analyses(50)
27-04-2026
RRE Ventures Acquisition Corp., a SPAC, filed an S-1/A registration statement on April 27, 2026, for an IPO of 25,000,000 units (each including one Class A ordinary share and one-third of a warrant), resulting in 33,333,333 ordinary shares and 15,343,333 warrants outstanding post-offering, assuming no over-allotment exercise and surrender of 1,250,000 founder shares. The sponsor, RRESponsor LLC, made an initial $25,000 investment and sold 2,748,000 Class B founder shares to management team affiliates and others. Warrants have an exercise price of $11.50 per share, become exercisable 30 days post-business combination, and expire five years thereafter.
- ·Up to 1,250,000 founder shares subject to forfeiture depending on underwriter over-allotment exercise
- ·Warrants exercisable at $11.50 per share, adjustable under certain conditions (e.g., to 115% of higher of Market Value or Newly Issued Price if below $9.20)
- ·Public warrants redeemable at $0.01 each if Class A share price >= $18.00 for 20 trading days in 30-day period, starting 120 days post-business combination
- ·Separate trading of shares and warrants prohibited until post-closing Form 8-K filed with audited balance sheet
- ·No fractional warrants issued; requires purchase of at least three units for whole warrant
27-04-2026
Verizon reported Q1 2026 total operating revenue of $34.4 billion, up 2.9% YoY, driven by 5.2% growth in wireless equipment revenue to $5.7 billion, record adjusted EBITDA of $13.4 billion (up 6.7% YoY), and adjusted EPS of $1.28 (up 7.6% YoY), with first positive Q1 postpaid phone net additions since 2013 at 55,000. Net income rose 3.3% YoY to $5.1 billion, cash flow from operations increased 2.6% to $8.0 billion, and free cash flow grew 4.0% to $3.8 billion. However, total unsecured debt increased to $142.5 billion from $131.1 billion (Q4 2025), net unsecured debt to $130.1 billion, wireless service revenue growth was impacted by an 80 basis point network outage effect, and full-year wireless service revenue is guided to be flat.
- ·Verizon paid down approximately half of Frontier debt since January 20, 2026 acquisition close; expects to repay substantially all by year-end.
- ·Raised 2026 guidance: Adjusted EPS $4.95-$4.99 (5.0-6.0% YoY growth); retail postpaid phone net adds upper half of 750,000-1M range.
- ·2026 outlook: Mobility/broadband service revenue growth 2.0-3.0% (~$93B); wireless service revenue flat; cash flow from ops $37.5B-$38.0B; capex $16.0B-$16.5B; FCF $21.5B+ (7.0%+ YoY growth).
27-04-2026
MetaVia Inc. (MTVA) has issued a proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 8, 2026, at 10:00 a.m. ET, seeking approval for electing two Class I directors for three-year terms, ratifying BDO USA, P.C. as independent auditors for FY 2026, a discretionary reverse stock split of 1-for-5 to 1-for-22, amending the 2022 Equity Incentive Plan to add 200,000 shares, and authorizing adjournments for Proposals 3 and 4 if needed. As of the April 13, 2026 record date, 5,164,370 shares of Common Stock (par value $0.001) were outstanding, with a quorum requiring one-third of voting power present. The Board unanimously recommends voting FOR all proposals; no financial performance metrics or period comparisons are discussed.
- ·Virtual meeting access: www.virtualshareholdermeeting.com/MTVA2026; requires 16-digit control number to vote remotely.
- ·Proxy voting deadline: 11:59 p.m. ET on June 7, 2026 via Internet.
- ·Proposal 1 (director election): plurality vote; Proposals 2, 4, 5: majority of voting power present; Proposal 3: majority of votes cast.
- ·Broker non-votes have no effect on any proposals; only Proposal 2 is routine (broker discretionary).
27-04-2026
As of March 31, 2026, Golub Capital Private Credit Fund's portfolio fair value stood at $9,928 million across 458 companies, with net asset value of $4,549 million and NAV per share declining 4.0% quarter-over-quarter to $24.14 from $25.15 due to unrealized losses from widened credit spreads, despite solid credit performance (97.7% in top IPR categories). The Fund declared regular April 2026 distributions of $0.1875 per share (net $0.1875 for Class I, $0.1704 for Class S) and boosted liquidity by amending its SMBC Credit Facility, increasing commitments by $525 million to $3,127.5 million at lower borrowing costs. Debt-to-equity leverage remained stable at 1.25x, with $1.85 billion in available liquidity.
- ·Debt-to-equity leverage ratio of 1.25x and GAAP debt-to-equity ratio, net, of 1.23x as of March 31, 2026.
- ·Top industries: Software (20%), Healthcare Technology (7%), Hotels/Restaurants/Leisure (7%).
- ·IPR 3 investments at 2.2% and IPR 1/2 at 0.1% of portfolio fair value.
- ·Distributions payable to shareholders of record April 30, 2026, paid on or around May 28, 2026.
- ·SMBC Credit Facility amendment also extended revolving period and maturity to 4 and 5 years, reduced margin to 1.75%.
27-04-2026
RE/MAX Holdings, Inc. announced a definitive agreement to be acquired by The Real Brokerage Inc., forming Real REMAX Group, a technology-enabled global real estate company, with the transaction expected to close in the second half of 2026 subject to approvals. RE/MAX, Motto Mortgage, and wemlo brands will continue operating independently post-close, maintaining the franchise model, while leveraging Real's technology platform. The combined entity will include over 180,000 real estate professionals across more than 120 countries, building on RE/MAX's current network of more than 145,000 agents.
- ·Business as usual until transaction closes; no immediate changes to operations, reporting structure, title, compensation, or benefits
- ·RE/MAX and Real brands to remain separate under the new company
- ·Dave Liniger stepping down as Chairman post-close
27-04-2026
Alliance Laundry Holdings Inc. has issued a proxy statement for its virtual Annual Meeting on June 11, 2026, seeking stockholder approval to elect three Class I directors—Michael D. Schoeb, Phyllis A. Knight, and Robert L. Verigan—to serve until the 2029 annual meeting; ratify Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026; approve on an advisory basis the frequency of future say-on-pay votes (Board recommends one year); and approve on an advisory basis the compensation of named executive officers. The Board consists of seven directors serving staggered three-year terms, with BDT Badger Holdings, LLC as the Principal Stockholder. As of the record date of April 16, 2026, 198,237,241 shares of common stock were outstanding.
- ·Annual Meeting is completely virtual via live webcast at www.virtualshareholdermeeting.com/ALH2026
- ·Record date for voting eligibility: April 16, 2026
- ·Board divided into three classes with staggered three-year terms per Fourth Amended and Restated Certificate of Incorporation
- ·Proxy materials and 2025 Annual Report available at http://www.proxyvote.com
27-04-2026
Qfin Holdings, Inc. reported total net revenue of RMB 19,205,059 thousand ($2,746,287 thousand) for the year ended December 31, 2025, up 11.9% YoY from RMB 17,165,656 thousand, driven by 19.3% growth in credit-driven services to RMB 13,977,218 thousand; however, platform services declined 4.1% to RMB 5,227,841 thousand, loan facilitation capital-light fees dropped 45.1% to RMB 1,162,563 thousand, and net income attributable to ordinary shareholders fell 4.4% to RMB 5,989,691 thousand ($856,516 thousand). Total assets expanded 18.4% to RMB 56,949,795 thousand ($8,143,711 thousand), supported by higher loans receivable, while provisions for credit losses rose significantly. Diluted EPS per ordinary share improved to 22.01 from 20.64 YoY.
- ·Hypothetical taxation scenario assumes 25% statutory tax rate in China, reduced by 5% withholding to 71.25% net distribution, noting preferential 15% rate for certain subsidiaries is temporary.
- ·Convertible senior notes current: RMB 1,019,130 thousand and noncurrent RMB 1,583,213 thousand as of Dec 31 2025.
- ·VIEs and subsidiaries contributed RMB 18,457,253 thousand net revenues in 2025 (96% of total).
- ·Diluted net income per ADS: 44.02 in 2025 vs 41.28 in 2024.
27-04-2026
Veradermics, a late-stage biopharma company, filed an S-1 registration statement disclosing positive topline data from its Phase 2/3 trial (Study ‘302’) in 519 male patients with pattern hair loss (PHL), meeting all co-primary endpoints with statistically significant non-vellus TAHC increases of 30.3 hairs/cm² (QD) and 33.0 hairs/cm² (BID) vs. 7.3 hairs/cm² for placebo at Month 6 (p<0.0001), and high PRO response rates of 79.3%-86.0% vs. 35.6% placebo. The company has fully enrolled two male registration-directed trials (Phase 2/3: 519 patients; Phase 3: 536 patients) and initiated a female Phase 2/3 trial targeting 552 patients, with male Phase 3 topline data expected in H2 2026. The U.S. PHL market is estimated at $9 billion annually, with VDPHL01 positioned as a potential first oral, non-hormonal FDA-approved therapy.
- ·VDPHL01 is an oral ER formulation of minoxidil at 8.5 mg QD or BID; Phase 1 showed nearly twice the plasma exposure over 12 hours vs. 2.5 mg IR minoxidil, sustained above hair growth threshold 2x longer, with peak below cardiac threshold and no SAEs.
- ·All trials assess two dose regimens over 52 weeks; co-primary endpoints: non-vellus hair count change per cm² and PRO hair coverage benefit at 24 weeks.
- ·Earliest patent expiry: 2043.
- ·Rapid onset observed as early as Month 2 with statistical separation from placebo on TAHC and IGA.
- ·Treatment generally well-tolerated with TEAE rates similar to placebo, lower discontinuation rates than placebo, no treatment-related SAEs or cardiac AESIs.
27-04-2026
Vertiv Holdings Co announced the closing of the acquisition of Strategic Thermal Labs, LLC by one of its wholly-owned subsidiaries on April 27, 2026, via a press release furnished as Exhibit 99.1. The disclosure was made under Regulation FD. No financial terms or impacts were detailed in the filing.
27-04-2026
Information Services Group, Inc. held its 2026 Annual Meeting of Stockholders on April 24, 2026, with 41,107,501 shares represented, achieving an 86.22% quorum out of 47,674,341 outstanding shares. Stockholders elected Samuel L. Molinaro Jr. (34,300,833 votes for, 580,993 withheld) and Gerald S. Hobbs (34,216,824 votes for, 665,002 withheld) as directors, ratified PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2026 (40,696,051 for, 354,826 against), and approved executive compensation on a non-binding advisory basis (34,336,931 for, 456,580 against). All proposals passed with strong majorities and no significant opposition.
- ·Broker non-votes: 6,225,675 for Proposals 1 and 3; none for Proposal 2.
- ·Proposal 2 abstentions: 56,624.
- ·Proposal 3 abstentions: 88,315.
27-04-2026
NCR Voyix Corporation filed a supplement to its April 21, 2026 proxy statement for the Annual Meeting of Stockholders on June 3, 2026. The supplement clarifies the voting standard for Proposal 4 (approval of the 2026 Stock Incentive Plan), replacing text on pages 71 and 95 to state that approval requires an affirmative vote of the majority of votes cast, with Series A Convertible Preferred Stock voting on an as-converted basis alongside common stock, and abstentions and broker non-votes having no effect. Stockholders who have already voted need not do so again unless they wish to change their vote.
- ·Supplement filed on April 27, 2026
- ·Voting clarification applies to Proposal 4 under Maryland law and Company charter/bylaws
27-04-2026
Adagio Medical Holdings, Inc. announced positive pivotal results for its vCLAS® Ventricular Ablation System in a press release issued on April 26, 2026. The announcement was filed as Exhibit 99.1 in this Form 8-K. No financial metrics or period-over-period comparisons were disclosed in the filing.
- ·Filing date: April 27, 2026; Event date: April 26, 2026
- ·Registrant is an emerging growth company
- ·Common Stock trades on Nasdaq under symbol ADGM
27-04-2026
Ultra Clean Holdings, Inc. (UCTT) has filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders on May 22, 2026, at 12:30 p.m. PT, held virtually only. Key proposals include electing directors, ratifying PricewaterhouseCoopers LLP as independent auditors for fiscal 2026, an advisory vote on named executive officer compensation, and approvals of amendments and restatements to the stock incentive plan and employee stock purchase plan. The record date is March 27, 2026, with 44,825,713 shares of common stock outstanding.
- ·Annual meeting is virtual only at www.virtualshareholdermeeting.com/UCTT2026; physical attendance not permitted.
- ·Proxy materials available at http://materials.proxyvote.com.
- ·Board recommends voting FOR all proposals.
27-04-2026
Velo3D, Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Stockholders scheduled for June 10, 2026, at 1:00 PM PT virtually. Key voting items include election of Class II directors Stefan Krause and Lily Mei, ratification of Frank, Rimerman + Co. LLP as independent auditors for FY 2026, advisory approval of named executive officer compensation, advisory vote on say-on-pay frequency (board recommends 1 year), and approval of an amendment to the 2021 Equity Incentive Plan. No financial performance data or period comparisons are provided in the materials.
- ·Vote deadline: June 9, 2026, 11:59 PM ET
- ·Proxy materials request deadline: May 27, 2026
- ·Virtual meeting link: www.virtualshareholdermeeting.com/VLD2026
- ·Filing date: April 27, 2026
27-04-2026
Velo3D, Inc. filed an 8-K/A amendment to clarify compensatory arrangements for CEO Arun Jeldi, specifying a one-time 2026 Performance Award of stock options sized at 3% of total outstanding common stock, with a 10-year term and vesting tied to market cap milestones of $1B (10%), $3B (additional 20%), $5B (additional 30%), and $10B (final 40%) within five years, replacing routine annual equity grants for 2026-2029. The award is expected shortly after the 2026 annual stockholder meeting, subject to available shares under the equity incentive plan. No financial performance metrics or changes are reported in this filing.
- ·Exercise price of options equal to fair market value per share on grant date.
- ·Vesting requires Mr. Jeldi to remain in service through each milestone achievement.
- ·If insufficient shares under EIP, award may be split or terms adjusted post-January 1, 2027 evergreen increase.
- ·Description qualified by full award agreement to be filed later.
27-04-2026
Velo3D, Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 10, 2026, seeking approval to elect two Class II directors (Stefan Krause and new nominee Lily Mei), ratify Frank, Rimerman + Co. LLP as independent auditors for the year ending December 31, 2026, approve advisory votes on named executive officer compensation and say-on-pay frequency (recommending every 1 year), and amend the 2021 Equity Incentive Plan by increasing authorized common shares by 2,860,000. The record date is April 15, 2026. No financial performance metrics or period-over-period comparisons are discussed.
- ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/VLD2026.
- ·Record Date: April 15, 2026.
- ·Filing Date: April 27, 2026.
- ·Board majority independent (3 out of 5 directors); all committees composed of independent directors.
27-04-2026
Driven Brands Holdings Inc.'s indirect wholly-owned subsidiaries, Driven Holdings Parent LLC and Driven Holdings, LLC, entered into a Fourth Amendment and limited waiver to their revolving credit facility under the Credit Agreement on April 24, 2026. The amendment waives any potential defaults from the intent to restate financial statements for fiscal years ending December 30, 2023, December 28, 2024, and the first three quarters of the fiscal year ending December 27, 2025, while extending the delivery deadline for FY2025 financials to June 10, 2026, and Q1 2026 financials to 45 days thereafter. This signals ongoing financial reporting challenges with no positive operational metrics disclosed.
- ·Fiscal quarters to restate: first three quarters of fiscal year ending December 27, 2025.
- ·Q1 2026 fiscal quarter ends March 28, 2026.
- ·Credit Agreement originally dated May 27, 2021.
27-04-2026
Oppenheimer Holdings Inc. (OPY) agreed to a $70 million settlement of the 'Cash Sweep' class action litigation filed in June 2025, avoiding a jury trial where plaintiffs sought over $440 million in damages based on discovery assertions. The settlement, subject to District Court approval within up to 90 days and formal documentation within 60 days, provides a full release of claims without admission of liability and is fully tax-deductible, but will significantly impact Q1 2026 earnings despite competitive rates during the disputed period from 2022. Class certification was granted on December 8, 2025, with trial set for June 2026.
- ·Litigation: Liberty Capital Group v. Oppenheimer Holdings Inc., et al., No. 1:25-cv04822-JSR, U.S. District Court Southern District of New York
- ·Company headquartered in New York with institutional businesses in London, Tel Aviv, and Hong Kong
- ·Earnings release expected May 1, 2026; Form 10-Q for quarter ended March 31, 2026 filed around same time
27-04-2026
ProFund Advisors LLC filed its 13F-HR on April 27, 2026, disclosing equity holdings as of March 31, 2026, across 1092 positions with sole voting power. The portfolio is dominated by large-cap technology stocks, with top holdings including Apple Inc. (458,970 shares valued at $116.48B), Broadcom Inc. (356,492 shares at $110.34B), Amazon.com Inc. (365,941 shares at $76.21B), Alphabet Inc. Class A (180,629 shares at $51.94B), and Alphabet Inc. Class C (162,795 shares at $46.70B). No prior period comparisons are available in this filing.
- ·Filing effective date: April 27, 2026
- ·Report period end: March 31, 2026
- ·All reported holdings have sole voting power (SH SOLE)
27-04-2026
B. Riley Wealth Advisors, Inc. filed its 13F-HR on April 27, 2026, for the quarter ended March 31, 2026, disclosing 898 equity positions totaling $1,579,184,022 in market value. The portfolio includes significant common stock holdings in technology leaders such as Apple Inc. ($55,050,792 for 223,212 shares), Amazon.com Inc. ($29,890,838 for 148,747 shares), and Broadcom Inc. ($17,208,384 for 58,650 shares), alongside ETFs, REITs, and options contracts across sectors like healthcare, energy, and finance. No period-over-period changes are detailed in this snapshot filing.
- ·Filing signed in Memphis, TN on April 24, 2026
- ·SEC file number: 028-13634
- ·Business address: 40 S. Main St., Suite 1600, Memphis, TN 38103
27-04-2026
Brown Financial Advisory filed its 13F-HR report for the quarter ended March 31, 2026, disclosing 49 equity holdings with a total market value of $201644295, all held with sole voting and dispositive power. The portfolio is diversified across individual stocks such as Apple Inc (1258040 value), Microsoft Corp (1210985 value), and Amazon.com Inc (526507 value), and various ETFs from providers like SPDR, Vanguard, and iShares. No changes or performance metrics were reported in this static holdings disclosure.
- ·Filing signed by Joshua Wyatt Lancaster on April 24, 2026
- ·Business address: 54 S. Greeno Road, Fairhope, AL 36532
- ·All holdings reported with sole voting power (SH SOLE) and no put/call options
27-04-2026
Private Advisor Group, LLC, an institutional investment manager based in Morristown, NJ, filed its Form 13F-HR on April 27, 2026, reporting U.S. equity holdings as of March 31, 2026, with a total market value of $21,326,197,825 across 2,735 securities. Notable positions include Apple Inc. ($555,247,952 for 2,187,826 shares), Amazon.com Inc. ($217,248,245 for 1,043,109 shares), and Alphabet Inc. Class A ($122,843,477 for 427,193 shares), alongside various ETFs, options, and smaller holdings. The filing discloses sole voting power for most positions, with no prior period comparisons provided.
- ·Report filed under SEC file number 028-15851
- ·Central Index Key: 0001567755
- ·Includes positions with put/call options (e.g., 200 Apple Inc. put shares, 500 Alphabet Inc. Class A call shares)
27-04-2026
Fortrea Holdings Inc. (FTRE) filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting scheduled virtually on June 9, 2026, at 8:00 A.M. ET. Key voting items include the election of three director nominees (Anshul Thakral, Peter M. Neupert, William J. Sharbaugh), ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026, and advisory approval of named executive officer compensation, with the Board recommending 'For' on all. Shareholders must vote by June 8, 2026, 11:59 PM ET, and can request paper copies of materials by May 26, 2026.
- ·Meeting held virtually at www.virtualshareholdermeeting.com/FTRE2026
- ·Proxy materials available at www.ProxyVote.com; control numbers provided (e.g., V85211-P49297)
- ·Company address: 8 Moore Drive, Durham, North Carolina 27713
- ·Filing date: April 27, 2026
27-04-2026
Fortrea Holdings Inc. (FTRE) filed a DEF 14A proxy statement for its virtual Annual Meeting on June 9, 2026, seeking stockholder approval to elect Anshul Thakral, Peter M. Neupert, and William J. Sharbaugh as Class III directors until the 2028 Annual Meeting, ratify Deloitte & Touche LLP as independent auditors for FY 2026, and conduct an advisory 'Say-on-Pay' vote on named executive officer compensation. As of the April 15, 2026 record date, 94,584,730 shares of common stock were outstanding. The company, a spin-off from Labcorp effective June 30, 2023, employs approximately 14,300 people across 100 countries providing clinical development services.
- ·Annual Meeting time: 8:00 a.m. Eastern Time, virtual at www.virtualshareholdermeeting.com/FTRE2026
- ·Proxy materials and 2025 Annual Report available at www.proxyvote.com as of April 27, 2026
- ·Compensation disclosures reference PEOs including Thomas Pike (2023-2024), Anshul Thakral and Peter Neupert (2025), with Appendix A on non-GAAP metrics
27-04-2026
Y-Intercept (Hong Kong) Ltd filed its 13F-HR on April 27, 2026, for the quarter ended March 31, 2026, disclosing 1,496 equity holdings with a total portfolio value of $5,274,758,272, all held with sole voting power. Top positions include Apple Inc at $56,149,007 (221,242 shares), Boston Scientific Corp at $28,254,505 (450,271 shares), Adobe Inc at $20,244,675 (83,284 shares), and AbbVie Inc at $20,373,593 (93,676 shares). No changes or performance metrics were reported in the filing.
- ·Filing covers period ended 20260331
- ·All positions reported as SH SOLE with 0 put/call shares
- ·Filer CIK: 0001772875, SEC file number: 028-20578
27-04-2026
Commercial Vehicle Group, Inc. (CVGI) filed its DEF 14A Proxy Statement on April 27, 2026, for the virtual Annual Meeting of Stockholders on May 14, 2026, seeking election of seven director nominees, approval of the Second Amended and Restated 2020 Equity Incentive Plan, an advisory vote to approve named executive officer compensation, and ratification of KPMG LLP as independent auditor for the fiscal year ending December 31, 2026. The statement includes executive compensation disclosures referencing Principal Executive Officers (PEOs) James R. Ray (2023-2025), Robert R. Griffin, and Harold Bevis (2021-2022). Record date is March 16, 2026.
- ·Virtual Annual Meeting: May 14, 2026, at 1:00 p.m. Eastern Time via www.virtualshareholdermeeting.com/CVGI2026 (16-digit control number required)
- ·Record Date: March 16, 2026
- ·Fiscal year references: 2025 (Jan 1 - Dec 31, 2025), 2024, 2023, 2022, 2021
27-04-2026
Easterly Government Properties reported Q1 2026 net income of $1.4 million ($0.03 per fully diluted share), reflecting modest GAAP profitability, alongside stronger Core FFO of $37.1 million ($0.77 per fully diluted share). The company acquired a 297,713 square foot campus leased primarily to the Commonwealth of Virginia and issued 94,170 shares via its 2021 ATM Program for net proceeds of $2.1 million, while entering a $7.0 million mezzanine loan at 12% interest. It raised full-year 2026 Core FFO guidance to $3.06-$3.12 per share amid stable portfolio operations across 106 properties totaling 10.7 million leased square feet, with total debt steady at $1.7 billion.
- ·Dividend of $0.45 per common share approved for Q1 2026, payable May 21, 2026 to shareholders of record on May 7, 2026.
- ·Full-year 2026 guidance assumes $50 million of wholly owned acquisitions and $50-$100 million of gross development-related investment.
- ·Acquisition on January 16, 2026, with lease expirations ranging from 2027 to 2036.
27-04-2026
Shoulder Innovations, Inc. issued a press release on April 27, 2026, announcing the full commercial launch of the InSet™ I-135RFX Humeral Stem. The press release is furnished as Exhibit 99.1 under Item 9.01 and incorporated by reference under Item 7.01 Regulation FD Disclosure. No financial metrics or performance comparisons were disclosed.
- ·Registrant is an emerging growth company.
- ·Common Stock trades on New York Stock Exchange under symbol 'SI'.
27-04-2026
Pintec Technology Holdings Ltd filed a Form F-3 shelf registration statement with the SEC on April 27, 2026, enabling the future issuance of various securities including Class A ordinary shares, preferred shares, debt securities, warrants, subscription rights, and units. The prospectus incorporates by reference the company's Annual Report on Form 20-F for the fiscal year ended December 31, 2025 (filed April 24, 2026) and the securities description from Form 8-A12B (filed October 19, 2018). No specific financial performance metrics, amounts, or period-over-period comparisons are disclosed in the filing itself.
- ·Legal opinions provided by Travers Thorp Alberga (Cayman Islands) and Beijing Shihui Law Firm (PRC matters).
- ·Auditor consent from Marcum Asia CPAs LLP.
- ·Contact for prospectus copies: J and Friends Holdings Limited, Room 02/a, 7/F, A T Tower, 180 Electric Road, North Point, Hong Kong (+852 5649 4870).
27-04-2026
uniQure N.V. filed definitive additional proxy materials (DEFA14A) for its Annual General Meeting on June 10, 2026, at 9:00 A.M. CEST in Amsterdam, covering proposals including adoption of the 2025 Dutch statutory annual accounts, discharge of board liability, reappointment of three non-executive directors, board authorizations for share issuance and repurchase, appointment of KPMG as 2026 auditor, advisory approval of executive compensation and frequency, and amendments to the 2014 Share Incentive Plan and Articles of Association. The Board recommends voting FOR Proposals 1-10 and 12-15, and 1 YEAR on Proposal 11. Proxy materials are available online at www.investorvote.com/QURE, with voting due by June 9, 2026, at 9:59 P.M. CEST.
- ·AGM location: Paasheuvelweg 25a, 1105 BP Amsterdam, the Netherlands
- ·Paper copy request deadline: May 29, 2026
- ·Proposals include designation of Board for share issuance/repurchase and preemptive rights exclusion
- ·Amendments to Articles of Association: Dutch large company regime, increased authorized share capital, federal forum selection provision
27-04-2026
uniQure N.V. filed its DEF 14A definitive proxy statement on April 27, 2026, for the 2026 Annual General Meeting on June 10, 2026, at 9:00 a.m. CEST in Amsterdam, covering adoption of 2025 Dutch statutory annual accounts, discharge of Board liability, and reappointments of non-executive directors Madhavan Balachandran, Jack Kaye, and Leonard Post, Ph.D. The agenda also includes authorizations for share issuances and repurchases, appointment of KPMG Accountants N.V. as 2026 external auditors, advisory votes on executive compensation and frequency, and amendments to the 2014 Share Incentive Plan (increasing available shares) and Articles of Association.
- ·Record date: close of business CEST on May 13, 2026.
- ·Voting deadline: 9:59 p.m. CEST on June 9, 2026; attendance notice by 12:00 p.m. CEST on June 9, 2026 via investors@uniQure.com.
- ·Meeting location: Paasheuvelweg 25a, 1105 BP Amsterdam, the Netherlands.
27-04-2026
Miami International Holdings, Inc. (MIAX) filed a definitive proxy statement (DEF 14A) on April 27, 2026, for its 2026 Annual Meeting of Stockholders on June 16, 2026, at 8:00 a.m. ET via live webinar with no physical location. Shareholders will vote on electing 15 directors to serve until the 2027 annual meeting, approving on a non-binding advisory basis the compensation of named executive officers and the frequency of future say-on-pay votes (every 1, 2, or 3 years), and ratifying KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.
- ·Record date for voting eligibility: April 20, 2026
- ·Virtual meeting access: www.virtualshareholdermeeting.com/MIAX2026 with 16-digit control number
- ·Proxy materials and Form 10-K for year ended December 31, 2025 available at http://ir.miaxglobal.com under 'SEC Filings'
27-04-2026
On April 23, 2026, the Board of Directors of Miami International Holdings, Inc. elected Eric Sites as a director to fill an existing vacancy, effective April 24, 2026, until the 2026 Annual Meeting of Shareholders or until his successor is elected and qualified. Mr. Sites has not been appointed to any Board committees and will receive standard non-employee director compensation, with no family relationships, related transactions, or arrangements disclosed regarding his election. He has entered into a standard indemnification agreement with the Company.
27-04-2026
Hemab ApS reported increasing net losses of $48,707 thousand in 2024 and $63,913 thousand in 2025, driven by a 44% YoY rise in R&D expenses to $59,632 thousand and higher cash burn from operations at $61,475 thousand. However, the company raised $156,421 thousand net from Series C convertible preference shares in 2025, boosting cash and equivalents to $87,974 thousand, marketable securities to $97,511 thousand, and total assets to $194,783 thousand. This S-1/A filing supports an IPO registration, highlighting clinical-stage assets like sutacimig (HMB-001) and HMB-002.
- ·Ordinary shares outstanding remained flat at 946,000 throughout 2024 and 2025.
- ·Stockholders’ deficit widened to $(176,635) thousand as of December 31, 2025 from $(115,273) thousand.
- ·Series C shares issued: 512,991 shares with liquidation preference of $156,898 thousand.
27-04-2026
Solstice Advanced Materials Inc. announced a quarterly dividend of $0.075 per share on April 27, 2026, payable on June 10, 2026, to shareholders of record as of the close of business on May 27, 2026. The press release detailing the dividend is filed as Exhibit 99.1.
- ·Filing date: April 27, 2026; Date of earliest event: April 24, 2026
- ·Common stock: par value $0.01 per share, trading symbol SOLS on Nasdaq
- ·Principal executive offices: 115 Tabor Road, Morris Plains, New Jersey 07950
27-04-2026
Miami International Holdings, Inc. (MIAX) filed a DEFA14A Definitive Additional Proxy Materials on April 27, 2026, consisting of a Notice and Proxy Card. The filing was submitted by the registrant, with Thomas P. Gallagher listed as the person filing if other than the registrant. No specific proposals, financial data, or shareholder actions are detailed in the provided content.
- ·Filing Type: DEFA14A (Definitive Additional Materials)
- ·Subcategory: Proxy Statement
- ·Payment of Filing Fee: No fee required
27-04-2026
Narodna banka Slovenska, the National Bank of Slovakia, filed a 13F-HR report on April 27, 2026, disclosing its equity holdings as of March 31, 2026. The portfolio consists of three sole-owned positions: Vanguard Total International Stock ETF valued at 1112817835 USD, Vanguard Total Stock Market ETF at 1762446557 USD, and Invesco Actively Managed Exchange Global Equity NE at 126551272 USD. No changes in holdings or performance metrics were reported in this filing.
- ·All holdings reported as SH SOLE with 0 shared voting authority and 0 other manager shares.
- ·Filing CIK: 0002126778; SEC File Number: 028-26828.
27-04-2026
Avient Corporation announced the resignation of Jamie A. Beggs as Senior Vice President and Chief Financial Officer, effective June 1, 2026, to pursue other professional opportunities, with no disagreements on company matters. The Board appointed internal executive Giuseppe (Joe) Di Salvo, age 48, as the new Senior Vice President and Chief Financial Officer effective the same date. Di Salvo's package includes a $560,000 annual base salary and a one-time $220,000 RSU grant vesting over three years.
- ·Resignation notified on April 22, 2026; appointment by Board on April 24, 2026.
- ·Di Salvo previously served as Corporate Controller (2013-2018), VP Investor Relations, and led Treasury and FP&A since 2019.
- ·Severance under Executive Severance Plan: two years salary continuation, pro-rated incentive, and benefits if terminated without cause (non-change in control).
- ·Change-in-control Continuity Agreement provides lump-sum severance of two years base salary and target incentive if terminated within 24 months post-change in control.
27-04-2026
Greenlane Holdings, Inc. regained compliance with Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement on April 21, 2026, leading to the cancellation of its delisting hearing scheduled for May 5, 2026, and continued trading of its Class A Common Stock (GNLN) on the Nasdaq Capital Market. Certain warrant holders affiliated with the board entered into Lock-Up Agreements on April 21, 2026, covering Warrants to purchase 162,760 shares of Common Stock, restricting sales until April 23, 2027. This resolves the delisting risk initially notified on March 25, 2026.
- ·Nasdaq notice received on March 25, 2026, for failure to maintain $1.00 minimum bid price for 30 consecutive business days.
- ·Strategic Advisory Agreement with Advisors dated October 23, 2025, issued Warrants with initial exercise date of April 23, 2026.
- ·Press releases issued on April 21, 2026 (Exhibit 99.1) and April 27, 2026 (Exhibit 99.2).
27-04-2026
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND filed its quarterly 13F-HR on April 27, 2026, disclosing 538 equity holdings as of March 31, 2026, with a total portfolio market value of $18343152577. Top positions include Apple Inc. ($1038165556, 4090648 shares), Amazon.com Inc. ($513067938, 2463475 shares), Alphabet Inc. CAP STK CL C ($410109973, 1429652 shares), and Alphabet Inc. CAP STK CL A ($474184714, 1648994 shares), all held solely with no other managers, puts, or calls reported.
- ·All reported holdings are designated as 'SOLE' with zero shares for other managers, put options, and call options.
- ·Portfolio includes positions across diverse sectors including technology (e.g., Broadcom Inc $353151838), financials (e.g., Bank of America Corp $85855088), and consumer (e.g., Costco Wholesale Corp $181874382).
27-04-2026
Keenova Therapeutics plc's DEF 14A Proxy Statement for the 2026 Annual General Meeting on June 2, 2026, highlights fiscal 2025 as a transformational year marked by the merger with Endo, Inc. (now Endo LP) and the spin-off of Par Health, Inc., repositioning the company as a U.S.-focused branded therapeutics firm targeting rare diseases. While emphasizing diversified portfolio growth in areas like rheumatology and neurology, it details extensive risks such as unrealized synergies, increased indebtedness, regulatory scrutiny, and potential litigation from transactions. Proposals include electing 9 directors, advisory votes on executive compensation and auditors, capital reduction, and Articles amendment.
- ·Record date: March 23, 2026
- ·Meeting location: Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland
- ·9 director nominees proposed for election (Proposals 1(a) through 1(i))
- ·Fiscal year ended December 31, 2025; refers to Form 10-K for performance details
27-04-2026
Commonwealth Equity Services, LLC filed its 13F-HR on April 27, 2026, disclosing institutional holdings as of March 31, 2026, across 4,299 securities including equities, ETFs, and closed-end funds. Notable positions include large allocations to Alphabet Inc. (Class A and C), Amazon.com Inc., and Advanced Micro Devices Inc., with no prior period data available in the filing for comparison. The report indicates sole voting power over all listed holdings and no put/call options.
- ·Filing period end date: March 31, 2026
- ·Filer address: 275 Wyman Street, Ste. 400, Waltham, MA 02451
- ·All holdings reported with sole voting power (SH SOLE) and no other voting authority or options
27-04-2026
Beacon Advisors Holdings, LLC disclosed total holdings of $186,977,163 across 37 positions in its 13F-HR filing for the period ended March 31, 2026, primarily consisting of ETFs with sole voting authority. Top holdings include iShares Core S&P 500 ETF ($16,222,220), Fidelity Covington Trust VLU Factor ETF ($13,441,973), and iShares Core MSCI Emerging Markets ETF ($12,927,635). The portfolio shows diversification into US equities, international markets, dividend growth, minimum volatility strategies, and treasuries, with one common stock position in PureCycle Technologies Inc.
- ·All positions held with sole voting authority; zero shared or other voting rights.
- ·Business address: 9011 Mountain Ridge Drive, Suite 200, Austin, TX 78759.
- ·Filing CIK: 0002114314; SEC file number: 028-26712.
27-04-2026
COCA-COLA EUROPACIFIC PARTNERS plc (CCEP) disclosed purchases of a total 1,291,910 ordinary shares between April 20-24, 2026, as part of its share buyback program. Transactions occurred on US Trading Venues (1,290,670 shares) and London Stock Exchange (1,240 shares), with volume weighted average prices ranging from USD 96.4203 to USD 97.9672 and GBP 72.8219. No period-over-period comparisons or performance metrics were provided.
- ·VWAP: USD 97.9672 (20 Apr US), GBP 72.8219 (20 Apr LSE), USD 96.4203 (21 Apr US), USD 96.5019 (22 Apr US), USD 96.9748 (23 Apr US), USD 97.9083 (24 Apr US)
- ·Trading venues: Primarily US Trading Venues; one transaction on London Stock Exchange
27-04-2026
Benchmark Financial Wealth Advisors, LLC filed its 13F-HR report disclosing $361,104,529 in equity holdings across 133 positions as of March 31, 2026. The portfolio features heavy ETF exposure including Schwab Strategic TR Intl Eqty ETF at $26,507,039, Vanguard Index Fds Total Stk Mkt at $25,675,624, and DoubleLine ETF Trust Opportunistic Co at $23,917,289, alongside notable individual stocks like NVIDIA Corporation at $11,541,108. No period-over-period changes are detailed in this snapshot filing.
- ·Filing date: April 27, 2026
- ·Report period end: March 31, 2026
- ·Business address: 2351 NW Boca Raton Blvd, Suite 100, Boca Raton, FL 33431
- ·All holdings reported as sole investment discretion
27-04-2026
Vista Credit Strategic Lending Corp. sold 170,417.733 shares of Class I common stock for $3,287,900 as of April 1, 2026 (finalized April 22, 2026), exempt from registration under Section 4(a)(2) and Regulation D/S. As of March 31, 2026, the preliminary NAV per share was $19.291 for each class of common stock, with total investments at fair market value and unfunded commitments of $1.9 billion and a debt-to-equity ratio of 0.66x. No shares of Class D common stock were outstanding.
- ·No shares of Class D common stock outstanding as of March 31, 2026.
- ·Debt-to-equity ratio of 0.66x as of March 31, 2026.
27-04-2026
Provident Trust Co, based in Waukesha, WI, filed its 13F-HR on April 27, 2026, reporting discretionary equity holdings as of March 31, 2026, with a total portfolio value of $4,782,705,488 across 22 positions, all held solely. Largest holdings include Alphabet Inc Cl A (2,786,854 shares valued at $801,387,736), Alphabet Inc Cl C (2,797,052 shares at $802,362,337), Visa Inc (1,179,848 shares at $356,597,260), Charles Schwab Corp (3,702,825 shares at $347,991,493), and Costco Wholesale Corp (470,364 shares at $468,684,801). No prior period data or changes are disclosed in this snapshot filing.
- ·SEC file number: 028-06481
- ·All holdings reported as SOLE discretionary with zero shared or other manager shares
- ·Business address: N16 W23217 Stone Ridge Drive, Suite 310, Waukesha, WI 53188
- ·Phone: 262-521-2300
27-04-2026
Tennessee Valley Asset Management Partners filed its 13F-HR on April 27, 2026, disclosing institutional holdings as of March 31, 2026, with a total portfolio value of $757071676 across 191 positions, primarily ETFs and equities held with sole voting power. Top holdings include SPDR S&P 500 ETF Trust (CUSIP 78464A854) valued at $137949693 (18.2% of portfolio), iShares Core S&P U.S. Growth ETF (464287671) at $51341500, and iShares U.S. Equity ETF (09290C103) at $45874893. The portfolio features no reported shared voting power or other changes from prior filings in this document.
- ·All positions held with sole voting power (SH SOLE); no shared power reported.
- ·Small options positions include 1 call on Novo-Nordisk (value $16), 2 calls on Citigroup (value $10750), and minor puts on Intel, Citigroup, Shopify.
- ·Firm address: 6025 Brookvale Lane, Suite 160, Knoxville, TN 37919.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
More from: Dow Jones 30 Stocks SEC Filings
🇺🇸 More from United States
View all →April 21, 2026
US Pre-Market SEC Filings Roundup — April 21, 2026
US Pre-Market SEC Filings Roundup
April 20, 2026
US Pre-Market SEC Filings Roundup — April 20, 2026
US Pre-Market SEC Filings Roundup
April 20, 2026
General Federal Contracts — April 20, 2026
General Federal Contracts
April 20, 2026
High-Value Federal Grants ($5M+) — April 20, 2026
High-Value Federal Grants ($5M+)